Skip to main content

Hoferka Stacey

Attached is a word document with multiple syndromes that we have found useful during the coagulopathy cluster situation. Most used queries are highlighted in yellow.

These queries were created in response to marijuana, particularly synthetic marijuana, tainted with anticoagulants often found in rodent poisons.

 

 

Submitted by Anonymous on
Description

In March 2018, the Illinois Department of Public Health (IDPH) was informed of a cluster of coagulopathy cases linked to SC use. By June 30, 2018, 172 cases were reported, including five deaths, where 74% were male and the mean age was 35.3 years (range: 18–65 years). All cases presented to an emergency department (ED) at least once for this illness. Ninety-four cases provided clinical specimens and all tested positive for brodifacoum, a long-acting anticoagulant used in rodenticide. Cases were reported to the health department by the Illinois Poison Control Center and direct reporting from hospitals. REDCap was the primary database for tracking cases and collecting demographic information, risk factor data and healthcare facility utilization, including number of ED visits. Syndromic surveillance was utilized to monitor ED visits related to the cluster, assist with case finding and provide situational awareness of the burden on the EDs and geographic spread. In this study, we retrospectively used syndromic surveillance along with the data in REDCap to quantify the number of ED visits per coagulopathy case, understand the reasons for repeat visits, and determine whether visits were captured in syndromic surveillance.

Objective: To determine whether emergency department (ED) visits were captured in syndromic surveillance for coagulopathy cases associated with an outbreak linked to synthetic cannabinoid (SC) use and to quantify the number of ED visits and reasons for repeat visits.

Submitted by elamb on
Description

Accuracy in identifying drug-related emergency department admissions is critical to understanding local burden of disease and assessing effectiveness of drug abuse prevention and overdose-reduction initiatives. In 2018 the Illinois Department of Public Health (IDPH) began implementation of a mandatory opioid overdose reporting law, applicable to all hospital emergency departments (ED). The mandate requires reporting of patient demographics, causal substance and antagonist ED administration within 48 hours of presentation. This reporting is not name-based. IDPH currently utilizes a near real-time syndromic surveillance (SyS) reporting system for all hospital ED, capturing most of the mandated criteria. Leveraging this existing system facilitates adherence to the mandate while imposing minimal additional burden of reporting on local hospitals. The Division of Patient Safety and Quality at IDPH has thus chosen to evaluate the completeness of overdose reporting and compliance with the opioid overdose mandate that have resulted from use of the current syndromic surveillance system.

Objective: To evaluate capacity of the BioSense ESSENCE platform and pre-defined overdose queries to identify emergency department admissions related to opioid overdose, in compliance with 2018 mandatory overdose reporting laws in Illinois.

Submitted by elamb on
Description

Communicable disease reporting from providers can be a time-consuming process that results in delayed or incomplete reporting of infectious diseases, limiting public health's ability to respond quickly to prevent or control disease. The recent development of an HL7 standard for automated Electronic initial case reports (eICR) represents an important advancement for public health surveillance. The Illinois Department of Public Health (IDPH) participated in a pilot with the Public Health Informatics Institute and an Illinois-based provider group to accept eICR reports for Gonorrhea and Chlamydia.

Objective: Comparison of content in eCR and ELR cases reporting Review technical challenges and strategies for data management

Submitted by elamb on
Description

Inter-jurisdictional data sharing can enhance disease surveillance capabilities for local, state, regional and national public health situational awareness and response. BioSense 2.0, a cloud-based computing platform for syndromic surveillance, provides participating local, state and federal health jurisdictions with the ability to share aggregated data; a functionality that is easily activated by selecting an administrative checkbox within the BioSense application. Checking the data-sharing box, however, is a considerable decision that comes with benefits and consequences. On May 20-21, 2013, nine city, county, and state public health department jurisdictions (mainly from the mid-western region of the U.S.) met to explore data sharing for Heat Related Illness (HRI) surveillance using BioSense 2.0. During the workshop, all participants agreed to share data (using the BioSense 2.0 front-end application) in real-time to investigate HRI trends in regional populations during May-August 2012, evaluated HRI case-definitions, and documented benefits and barriers to inter-jurisdictional data sharing. The workshop was convened by ISDS, in collaboration with the Association of State and Territorial Health Officials (ASTHO), with the support of the U.S. Centers for Disease Control and Prevention. Staff from BioSense programmatic and technical teams were also present for the workshop.

Objective

Build upon the findings of a Regional Data Sharing workshop with the larger surveillance community to more clearly describe the benefits, barriers, and needs for data sharing on the BioSense 2.0 platform.

Submitted by knowledge_repo… on
Description

Comparison of heat-related health effects across regions or among different syndromic surveillance systems is problematic due to the lack of a standardized heat-related syndrome definition. While a national standard for common heat-related syndromes would facilitate data comparisons, local customization of syndromes to adjust for unique public health events or characteristics is often necessary to optimize use of syndromic surveillance data.

Objective

To determine differences in case detection using different syndrome definitions for heat-related health effects.

Submitted by knowledge_repo… on
Description

In 2016, the BioSense Platform for national syndromic surveillance made substantial enhancements including data processing changes, a national ESSENCE instance, and management tools to support diverse data sharing needs. On August 21, 2017, a total solar eclipse occurred over much of the United States. The event resulted in large gatherings over multiple days to areas in the Path of Totality (PoT). In the days leading up to the event, public health and emergency preparedness included syndromic surveillance in their monitoring plans. To support this effort, Illinois (IL), Kentucky (KY), and Tennessee (TN) established inter-jurisdictional aggregate data sharing to get a more inclusive view of cause-specific illness or injury in Emergency Department (ED) visits before, during, and after the eclipse.

Objective:

Describe cross-jurisdictional data sharing practices using ESSENCE and facilitated by the BioSense Platform for a national mass gathering event, and the dashboard views created to enhance local data for greater situational awareness.

Submitted by elamb on
Description

Syndromic surveillance has been widely implemented for the collection of Emergency Department (ED) data. EDs may be the only option for seeking care in underserved areas, but they do not represent population-based measures. This analysis provides insight on health-seeking behaviors within the context of the type of care sought.

Objective:

To analyze differences in utilization of Emergency Departments for primary care sensitive conditions by facility and by patient ZIP code.

Submitted by elamb on
Description

The mission of the ISDS TCC is to bridge the gap between the analytic needs of public health practitioners and the expertise of researchers from other fields for the enhancement of disease surveillance, including situational awareness of chronic as well as infectious threats and follow-up activities such as case linkage and contact tracing. Committee activities to achieve this mission are identifying practical use cases, refining technical specifications in open forums, obtaining benchmark datasets for controlled dissemination, validating candidate methods, and sharing method documentation. In its first 2 years, the TCC has worked on three use cases and assisted with development of data use agreements to permit posting of benchmark datasets, http://www.syndromic.org/ communities/technical-conventions. Recent polling of the Biosense User Group indicated widespread interest in developing additional use cases. The proposed panel is intended to focus on practical applications of common interest, refine the use case development and dissemination process, and foster global interest in this process.

Objective

The main objective is to broaden the collection of use cases developed by the ISDS Technical Conventions Committee (TCC) to enhance effective collaboration between public health practice and analyst researchers in various disciplines and institutions. Panellists will present and motivate use case concepts including requirements for practical solution methods. Component objectives are to refine the presented use cases and to stimulate formation of new ones at local, state, and national levels.

Submitted by teresa.hamby@d… on
Description

Meaningful Use (MU) Stage 2 public health reporting for Eligible Professionals (EPs) included a menu option for ambulatory syndromic surveillance. Review of currently existing models lead to a collaboration between the Illinois Health Information Exchange (ILHIE) and IDPH to build services that would support the use of the MPI, a database that can uniquely match records across systems. The MPI providers a mechanism for public health to manage multiple data streams, while maintaining confidentiality of health information and supporting the mission of public health to identify patterns of illness, apply effective interventions and conduct program evaluation. This initiative will allow IDPH to extend the use of the MPI to other surveillance domains, including hospital discharge, communicable disease, cancer and extensively drug resistance organism reporting.

Objective

This presentation will describe public health efforts to improve data collection by utilizing technology that supports record linkage through the implementation of the Master Patient Index (MPI). The initial use case will be applied to ambulatory syndromic surveillance at Illinois Department of Public Health (IDPH). It will include applications for incorporating the MPI into currently existing public health surveillance data and benefits to data integration and bidirectional information exchange.

Submitted by teresa.hamby@d… on